Journal Information
Vol. 6. Issue 1.
Pages 71 (January - February 2010)
Share
Share
Download PDF
More article options
Vol. 6. Issue 1.
Pages 71 (January - February 2010)
Full text access
Ageusia associated to treatment with pregabalin
Ageusia asociada a tratamiento con pregabalina
Visits
4665
Victor González Vallés, Javier Calvo Catalá
Corresponding author
calvo_jav@gva.es

Corresponding author.
, Cristina Campos Fernández, Amalia Rueda Cid
Unidad de Reumatología y Metabolismo Óseo, Consorcio Hospital General Universitario, Valencia, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
I.W. Tremon-Lukaats, C. Megeff, M.M. Backonja.
Anticonvulsionants for neuropathic pain syndromes: Mechanism of action and place in therapy.
Drugs, 60 (2000), pp. 1029-1052
[2.]
J. López-Trigo, J. Sancho.
Pregabalina: un nuevo tratamiento para el dolor neuropático.
Neurología, 21 (2006), pp. 96-103
[3.]
D.M. Tassone, E. Óbice, J. Guyer, D. Nuzum.
Pregabalin: A novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial onset seizures, and anxiety disorders.
[4.]
R.I. Henkin.
Drug induced taste and smell disorders.
Drug safety, 11 (1994), pp. 318-377
Copyright © 2010. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?